Search over 3,000 reports

    Humira- Drug Insight, 2017

    Humira- Drug Insight, 2017
    Date: Jan, 2018
    Type: Pharmaceutical Industry Report
    Pages: 35
    Geography: Global
    Delivery Timeline: 48 hours
    SKU: DIDI0362
    "Humira - Drug Insight, 2018" report by DelveInsight provides comprehensive information of the drug, Humira. It includes Humira`s overview, mechanism, clinical trials, regulatory milestones, deals & partnerships. It further provides Humira`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted sales of Humira till 2020. The report also throws light on Humira`s market competition and emerging therapies in the same space as Humira. A SWOT analysis of Humira is also featured.
    * Depending on information availability

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report
    • A comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
    • Patent information around Humira in United States (US) and Europe (EU) has been highlighted
    • API manufacturers for Humira in United States, Europe, China and India
    • The report contains historical and forecasted sales for Humira till 2020
    • Comprehensive coverage of the emerging therapies (Phase III) in the space where Humira operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
    • The report also features the SWOT analysis of Humira

    Reasons to Buy
    • Establish a comprehensive understanding of the drug, Humira
    • Access to Humira`s API manufacturers details to devise API procurement strategy for generic development
    • Plan developmental timelines around Humira`s patents for the major markets- US and EU
    • Understand Humira`s current and future growth through its historical and forecasted sales
    • Identify and understand the current in-market competitors for Humira
    • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
    • Identify and plan ahead for prospective emerging players and their products operating in the same space as Humira
    • Identify opportunities in the same area as Humira with DelveInsight`s SWOT analysis
    1. Report Introduction
    2. Humira - Overview
    • Product Description
    • Route of Synthesis
    • Mechanism of Action
    • Pharmacology
    • Pharmacodynamics
    • Pharmacokinetics
    • Adverse Reactions
    • Clinical Trials
    • Regulatory Milestones
    • Product Development Activities
    3. Global API Manufacturers
    • United States
    • Europe
    • China
    • India
    4. Product Details
    • United States
    • Europe
    5. Humira Global Sales Assessment
    • Historical Global Sales
    • Forecasted Global Sales
    6. Patent Details
    7. Market Competition
    8. Emerging Therapies
    8.1. Drug name: Company name
    • Product Description
    • Research & Development
    • Product Development Activities
    Other product profiles in the detailed report…..
    9. SWOT Analysis
    Consulting Services
    About DelveInsight
    Contact Us
    Note: Certain sections of the table of contents would vary according to the availability of information
    Table 1: Humira, Description
    Table 2: API Manufacturers Region wise
    Table 3: API Manufacturers for United States
    Table 4: API Manufacturers for Europe
    Table 5: API Manufacturers for China
    Table 6: API Manufacturers for India
    Table 7: Humira Product Details, United States
    Table 8: Humira Product Details, Europe
    Table 9: Humira, Historical Global Sales till 2017 (in million USD)
    Table 10: Humira, Forecasted Global Sales from 2018-2020 (in million USD)
    Table 11: Patent Details: Humira
    Table 12: Humira Major Competitors
    Table 13: Emerging Therapies
    Figure 1: Humira
    Figure 2: Humira, Historical Global Sales till 2017 (in million USD)
    Figure 3: Humira, Forecasted Global Sales from 2018-2020 (in million USD)
    Figure 4: Patent Details: Humira
    Figure 5: API Manufacturers Region wise

    Humira Marketed Drugs Overview

    Humira Market Assessment

    Humira API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers

    Humira US DMF

    Humira US Drug Master Files

    Humira Active Substance Master File/ EUDMF

    Humira Generic players

    Humira Patent Expiration

    Humira Patent Exclusivity

    Humira API Manufacturers

    Humira Global Forecasted Sales Figure

    Humira API Route of Synthesis

    Humira Market sales

    Humira SWOT Analysis

    Humira Pipeline

    • Single User License
      (20% Off)
    • Site License
      (30% Off)
    • Global License
      (40% Off)

    Contact Us

    +91-11-45689769, +91 9650213330


    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap